Abbvie Inc. signed a $1.1 billion New Year’s Eve deal with China’s Zelgen Biopharmaceuticals Co. Ltd., gaining ex-China ...
Four optimization trends dominated the med-tech industry in 2025. Growth-driven acquisitions propelled major players into hot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback